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ABSTRACT
Boerhaave syndrome or spontaneous rupture of the oesophagus is a severe condition commonly misdiagnosed or unrecognized. 
Prognosis is poor even if the diagnosis is made promptly. We describe a case of Boerhaave syndrome diagnosed after the development of 
pneumomediastinum and cardiac arrest. Unfortunately, the patient died 48 hours after admission to the Intensive Care Unit. This entity 
requires a multidisciplinary management approach which may include conservative, surgical or endoscopic procedures.
LEARNING POINTS
• Boerhaave syndrome is a diagnostic and therapeutic challenge, and rapid diagnosis and management are crucial. 
•	 A	thoraco-abdominal	CT	scan	with	oesophageal	opacification	is	the	gold	standard	investigation.	
• A multidisciplinary and individualized approach is needed in the management of this condition.
KEYWORDS
Boerhaave syndrome, pneumomediastinum, conservative, surgical, endoscopic
INTRODUCTION
Spontaneous perforation of the oesophagus, also referred to as Boerhaave syndrome, is the longitudinal rupture of a previously unremarkable 
oesophagus[1]. This spontaneous perforation commonly results from the sudden increase of pressure within the oesophageal lumen caused 
by	uncoordinated	oesophageal	motility	during	forceful	vomiting.	The	diagnosis	is	difficult	due	to	the	incidental	nature	of	the	disorder	and	
because	its	symptoms	are	often	inconsistent	and	non-specific.	Boerhaave	syndrome	must	be	treated	as	a	life-threatening	emergency	as	it	
has a mortality rate of up to 40%[2].
CASE DESCRIPTION 
A 90-year-old patient with a history of hypertension, diabetes type 2 and chronic alcoholism was admitted to the emergency department 
for cough, dyspnoea and abdominal pain. The initial work-up was consistent with pulmonary and urinary tract infections and so empiric 
treatment with ceftriaxone (1 g daily) was initiated. 
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On day 2 of admission in the geriatric department, the patient abruptly presented sharp chest pain accompanied by severe shortness of 
breath and vomiting. On physical examination, he was tachycardic (heart rate 100 beats/min), blood pressure was 100/60 mmHg, respiratory 
rate was 30 per min and oxygen saturation on room air was 85%. He was afebrile and saturation increased to 95% under 3 litres of oxygen. 
Diffuse	rales	were	heard	in	both	pulmonary	fields.	No	murmurs	or	pericardial	rubbing	was	noted.	The	abdomen	was	not	painful	with	any	
masses. Subcutaneous crepitus in the chest was noted. 
Blood tests showed mild hyperleukocytosis (14,000 mm3), elevated C-reactive protein (80 mg/l) and hyponatraemia (128 mmol/l). Liver, 
renal and coagulation tests were within normal ranges. Arterial blood gas analysis revealed hypoxaemia (pO
2
: 60 mmHg) and metabolic 
acidosis. The electrocardiogram was normal. A chest x-ray showed left paramediastinal clarity (pneumomediastinum), and cervical and 
axillary subcutaneous emphysema without associated pneumothorax.
The patient was transferred to the ICU. A few hours after admission, he experienced severe sinus bradycardia (33 beats/min), hypotension 
and stupor which preceded cardiac arrest. The patient was resuscitated. 
A second chest x-ray showed the previously described lesions were stable. Once he was haemodynamically stable, the patient was sent for 
a thoracic scan which showed a left pleural effusion and a prominent pneumomediastinum with suspicion of a distal oesophageal breach. 
These results were consistent with Boerhaave syndrome (Figs. 1–3). Broad-spectrum intravenous antibiotic therapy with meropenem 
was initiated. However, surgical treatment was not undertaken in light of the patient’s comorbidities and general condition. Endoscopic 
treatment was proposed but refused by the family. Supportive treatment was started and the patient died 48 hours later.
Figure 1. Chest radiograph showing a significant pneumomediastinum with sub-
cutaneous emphysema in the cervical and axillary regions. A left pleural effusion is 
also seen
Figure 2. Non-enhanced CT scan showing a large pneumomediastinum surrounding 
the oesophagus. A small effusion is seen in the left pleura. No pulmonary mass, 
pneumothorax or bone lesion is seen in the thorax
DISCUSSION
Boerhaave	syndrome	or	spontaneous	rupture	of	the	oesophagus	is	a	rare	and	often	fatal	condition.	It	is	defined	as	complete	rupture	of	the	
oesophageal wall following a sudden increase in intra-oesophageal pressure as the result of intraluminal hyperpressure with a closed glottis. 
It can also result from faecal vomiting, an epileptic seizure, an asthma attack or the Heimlich manoeuvre[1]. This entity has been mainly 
described in men (80% of cases) between the fourth and sixth decades of life.
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Figure 3. Non-enhanced CT scan showing a large pneumomediastinum surrounding the oesophagus. A small effusion is seen in the left pleura. No pulmonary mass, 
pneumothorax or bone lesion is seen in the thorax
The mortality rate varies from 28% to 85% depending on how quickly treatment is initiated [1, 2]. Rupture is more common in the lower third 
and	on	the	left	side	of	the	oesophagus,	due	to	parietal	sheet	weakness.	The	clinical	picture	is	non-specific,	making	diagnosis	difficult.	The	
chest pain and dyspnoea do not help diagnosis as they are frequently observed in other diseases. There can be signs of sepsis and shock as a 
result of mediastinal, pleural or abdominal infection. 
The presence of vomiting, chest pain and subcutaneous emphysema is known as Mackler's triad, which is pathognomonic but rarely seen 
in	clinical	practice.	Laboratory	investigations	are	not	helpful	as	they	are	non-specific.	Chest	x-ray	may	show	indirect	and	non-specific	signs	
such as pneumomediastinum, pneumoperitoneum, subcutaneous emphysema and unilateral or bilateral pleural effusion.
A thoracic CT scan is the gold standard for diagnosis and has a sensitivity of 92–100%. It usually shows pneumomediastinum and allows 
identification	of	the	oesophageal	breach	by	contrast	leak[2,3]. Performance of an upper gastrointestinal endoscopy is controversial despite its 
excellent	sensitivity	(100%)	and	specificity	(92%)	because	it	may	increase	injuries	and	favour	mediastinal	contamination.
In this case, diagnosis was based upon the anamnesis, the clinical picture and the results of the chest x-ray and scan which allowed tension 
pneumothorax and tension pneumomediastinum to be ruled out.
The management of Boerhaave syndrome includes medical, endoscopic or surgical procedures, depending on clinical stability. Medical 
treatment consists of early broad-spectrum empiric antibiotics, intravenous proton pump inhibitors and parenteral nutrition. Surgery is 
required if clinical worsening occurs during medical management,. Patients with underlying comorbidities who are unlikely to tolerate 
surgery	 may	 benefit	 from	 endoscopic	 therapy	 with	 a	 self-expandable	 stent.	 There	 is	 no	 real	 consensus	 about	 management	 since	 no	
prospective randomized trials have yet been published[4,5]. In this case, surgical management was not an option given the comorbidities of 
the patient and endoscopic treatment was refused by the family.
Increasing	life	expectancy	means	patients	require	a	case-by-case	approach,	where	the	risks	and	benefits	of	invasive	treatments	for	each	
patient are carefully considered.
CONCLUSION 
Boerhaave	syndrome	is	a	rare	condition	difficult	to	diagnose.	It	is	a	serious	medical	emergency,	as	in	this	case.	Prognosis	is	poor	and	survival	
depends on early diagnosis and treatment. Management must be multidisciplinary and individualized.
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